Cost of coronary syndrome treated with percutaneous coronary intervention and 30‐day unplanned readmission in the United States

Kwok, Chun Shing; Amin, Amit P.; Shah, Binita; Kinnaird, Tim; AlKutshan, Raed; Balghith, Muhammad; Ratib, Karim; Nolan, James; Bagur, Rodrigo; Mamas, Mamas A.

doi:10.1002/ccd.28660

Cited by 5 publications

(4 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This underscores the importance of using PCI in the appropriate patient population. Of note, data from the U.S. NIS from 2010 to 2014 reported that the 30-day hospital cost of PCI is approximately USD 10.8 billion per year [82], representing a significant financial burden to the U.S. healthcare system. As a result, it is also critical to determine which patients will optimally benefit from PCI to avoid an unnecessary economic burden.…”

Section: Cad Revascularization-challenges With Access Appropriate Use...mentioning

confidence: 99%

Challenges and Burdens in the Coronary Artery Disease Care Pathway for Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Narrative Review

Kodeboina

Piayda

Jenniskens

et al. 2023

IJERPH

View full text Add to dashboard Cite

Clinical and economic burdens exist within the coronary artery disease (CAD) care pathway despite advances in diagnosis and treatment and the increasing utilization of percutaneous coronary intervention (PCI). However, research presenting a comprehensive assessment of the challenges across this pathway is scarce. This contemporary review identifies relevant studies related to inefficiencies in the diagnosis, treatment, and management of CAD, including clinician, patient, and economic burdens. Studies demonstrating the benefits of integration and automation within the catheterization laboratory and across the CAD care pathway were also included. Most studies were published in the last 5–10 years and focused on North America and Europe. The review demonstrated multiple potentially avoidable inefficiencies, with a focus on access, appropriate use, conduct, and follow-up related to PCI. Inefficiencies included misdiagnosis, delays in emergency care, suboptimal testing, longer procedure times, risk of recurrent cardiac events, incomplete treatment, and challenges accessing and adhering to post-acute care. Across the CAD pathway, this review revealed that high clinician burnout, complex technologies, radiation, and contrast media exposure, amongst others, negatively impact workflow and patient care. Potential solutions include greater integration and interoperability between technologies and systems, improved standardization, and increased automation to reduce burdens in CAD and improve patient outcomes.

show abstract

Section: Cad Revascularization-challenges With Access Appropriate Use...mentioning

confidence: 99%

Challenges and Burdens in the Coronary Artery Disease Care Pathway for Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Narrative Review

Kodeboina

Piayda

Jenniskens

et al. 2023

IJERPH

View full text Add to dashboard Cite

show abstract

“…In this issue of Catheterization and Cardiovascular Interventions, Kwok et al 1 examine the costs associated with readmission after percutaneous coronary intervention (PCI). They evaluated patients in the National Readmission Database from 2010 and 2014 and identified costs incurred within 30 days of an index PCI.…”

Section: Condition 30‐day Readmission Rate Cost Per Readmission Citationmentioning

confidence: 99%

Interventional economics provide a roadmap to better patient care

Maestas

Blankenship

2021

Cathet Cardio Intervent

View full text Add to dashboard Cite

Key Points Costs of percutaneous coronary intervention including the index procedure and care in the subsequent 30 days are increased by half for patients who are readmitted, and increased up to two‐fold for those who have major adverse events during the initial admission. Many factors “predicting” adverse events and readmission are not modifiable. However, some are modifiable. Interventionalists should focus on those. In addition to using strategies to avoid adverse events, interventionalists should lead teams to implement strategies to prevent readmission. This will require a new nonprocedural focus for interventionalists.

show abstract

“…1 Percutaneous coronary intervention (PCI) accounts for more than $10 billion per year in hospital costs alone. 2 While there were initial reductions in the volume of PCIs performed for stable coronary artery disease (CAD) after the publication of the Appropriate Use Criteria for Coronary Revascularization in 2009, 3 PCI rates have since then largely remained stable. 4 As such, an opportunity for intervention (pardon the pun) still exists in this domain.…”

mentioning

confidence: 99%

Is cost-effectiveness the “tie-breaker” when deciding between anatomic and functional evaluation in stable ischemic heart disease?

Riedy

Phillips

2022

Journal of Nuclear Cardiology

View full text Add to dashboard Cite

show abstract

Cost of coronary syndrome treated with percutaneous coronary intervention and 30‐day unplanned readmission in the United States

Cited by 5 publications

References 28 publications

Challenges and Burdens in the Coronary Artery Disease Care Pathway for Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Narrative Review

Challenges and Burdens in the Coronary Artery Disease Care Pathway for Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Narrative Review

Interventional economics provide a roadmap to better patient care

Is cost-effectiveness the “tie-breaker” when deciding between anatomic and functional evaluation in stable ischemic heart disease?

Contact Info

Product

Resources

About